Key result
Percutaneous closure of a secundum atrial septal defect with an Amplatzer device in a 17-year-old male with acute myocardial ischemia resulted in no recurrence over 2 years.
Why the study?
Does percutaneous closure with an Amplatzer device prevent recurrence of myocardial ischemia in a patient with ASD and presumed paradoxical coronary embolism?
Case Report (n=1)
Does percutaneous closure with an Amplatzer device prevent recurrence of myocardial ischemia in a patient with ASD and presumed paradoxical coronary embolism?
Percutaneous closure of an ASD may effectively prevent recurrence of acute myocardial ischemia caused by presumed paradoxical coronary embolism.
May support ASD closure to avert recurrent paradoxical embolism; hypothesis-generating and requires prospective confirmation before practice change.
We describe a 17-year-old male with a secundum atrial septal defect (ASD), who presented with acute myocardial ischemia. The presumptive diagnosis of a paradoxical coronary embolism was based on the demonstration of a large ASD in conjunction with normal coronary arteries, a negative endomyocardial biopsy, and a negative drug screen. After percutaneous closure with an Amplatzer device, there has been no recurrence for 2 years.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2005) conducted a case report in Secundum atrial septal defect with acute myocardial ischemia (n=1). Percutaneous closure with an Amplatzer device was evaluated on Recurrence of myocardial ischemia. Percutaneous closure of a secundum atrial septal defect with an Amplatzer device in a 17-year-old male with acute myocardial ischemia resulted in no recurrence over 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: